CVE-2010-0684

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in createDestination.action in Apache ActiveMQ before 5.3.1 allows remote authenticated users to inject arbitrary web script or HTML via the JMSDestination parameter in a queue action.

Category

3.5
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.29%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://issues.apache.org/activemq/browse/AMQ-2613 exploit
http://www.securityfocus.com/archive/1/510419/100/0/threaded mailing list
http://securitytracker.com/id?1023778 vdb entry exploit
https://exchange.xforce.ibmcloud.com/vulnerabilities/57397 vdb entry
http://activemq.apache.org/activemq-531-release.html patch
http://www.securityfocus.com/bid/39119 vdb entry patch
http://secunia.com/advisories/39223 third party advisory vendor advisory
https://issues.apache.org/activemq/browse/AMQ-2625 exploit
http://www.rajatswarup.com/CVE-2010-0684.txt exploit

Frequently Asked Questions

What is the severity of CVE-2010-0684?
CVE-2010-0684 has been scored as a low severity vulnerability.
How to fix CVE-2010-0684?
To fix CVE-2010-0684, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-0684 being actively exploited in the wild?
It is possible that CVE-2010-0684 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.